BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17137483)

  • 1. Bier's white spots associated with scleroderma renal crisis.
    Peyrot I; Boulinguez S; Sparsa A; Le Meur Y; Bonnetblanc JM; Bedane C
    Clin Exp Dermatol; 2007 Mar; 32(2):165-7. PubMed ID: 17137483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, management and prevention of scleroderma renal disease.
    Penn H; Denton CP
    Curr Opin Rheumatol; 2008 Nov; 20(6):692-6. PubMed ID: 18946330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal crisis in scleroderma].
    Fagel WJ; van Es LA
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2588-90. PubMed ID: 1480244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Normotensive scleroderma renal crisis].
    Villaverde M; González A; Orellano P; Lafage M
    Medicina (B Aires); 2003; 63(1):49-50. PubMed ID: 12673962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improvement in scleroderma kidney with captopril].
    Ben David A; Blau A; Rapoport G
    Harefuah; 1994 Oct; 127(7-8):234-5, 287. PubMed ID: 7813949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A patient with systemic scleroderma showing improvement during long-term hemodialysis after renal crisis].
    Fuse Y; Muramatsu M; Sugiyama S; Maeda K
    Ryumachi; 1997 Aug; 37(4):574-80. PubMed ID: 9311284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls.
    Guillevin L; Bérezné A; Seror R; Teixeira L; Pourrat J; Mahr A; Hachulla E; Agard C; Cabane J; Vanhille P; Harle JR; Deleveaux I; Mouthon L
    Rheumatology (Oxford); 2012 Mar; 51(3):460-7. PubMed ID: 22087012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleroderma renal crisis: patient characteristics and long-term outcomes.
    Penn H; Howie AJ; Kingdon EJ; Bunn CC; Stratton RJ; Black CM; Burns A; Denton CP
    QJM; 2007 Aug; 100(8):485-94. PubMed ID: 17601770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney crisis in systemic sclerosis.
    Lewandowski B; Domysławska I; Klimiuk PA; Sierakowski S
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():294-6. PubMed ID: 16119690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Administration of angiotensin I converting enzyme inhibitor captopril, in a case of renal crisis of scleroderma--the effects of captopril to the temperature of the skin lesion in scleroderma (author's transl)].
    Gotoh S; Ogihara T; Hata T; Maruyama A; Naka T; Nakamaru M; Mikami H; Masuo K; Kumahara Y
    Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1133-41. PubMed ID: 7033607
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term outcomes of scleroderma renal crisis.
    Steen VD; Medsger TA
    Ann Intern Med; 2000 Oct; 133(8):600-3. PubMed ID: 11033587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resolution of scleroderma renal crisis with thrombotic microangiopathy. Case report (author's transl)].
    Rebaiz K; Birembaut P; Charneau A; Petit J; Wolf C
    Nephrologie; 1980; 1(3):137-41. PubMed ID: 7027064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal involvement in patients with systemic sclerosis].
    Bussone G; Noël LH; Mouthon L
    Nephrol Ther; 2011 Jun; 7(3):192-9. PubMed ID: 21524952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
    Teixeira L; Mouthon L; Mahr A; Berezné A; Agard C; Mehrenberger M; Noël LH; Trolliet P; Frances C; Cabane J; Guillevin L;
    Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal involvement in systemic sclerosis].
    Guerini S; Cavazzana I; Venturelli C; Rozzi M; Turina S; Sottini L; Tardanico R; Franceschini F; Scolari F
    G Ital Nefrol; 2007; 24(4):295-310. PubMed ID: 17659501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of captopril in the treatment of "scleroderma renal crisis".
    Chapman PJ; Pascoe MD; van Zyl-Smit R
    Clin Nephrol; 1986 Aug; 26(2):106-8. PubMed ID: 3530566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.
    Steen VD; Costantino JP; Shapiro AP; Medsger TA
    Ann Intern Med; 1990 Sep; 113(5):352-7. PubMed ID: 2382917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal scleroderma crisis. Role of scleroderma vasculopathy in the induction of cutaneous and visceral fibrosis in 2 cases].
    Cuchacovich M; Holuigue G; Gatica H; Alvo M; Murray G
    Rev Med Chil; 2000 Jan; 128(1):86-92. PubMed ID: 10883527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HHV-8 positive Kaposi sarcoma in a patient with end-stage renal disease undergoing hemodialysis: no regressive effect of captopril.
    Yaşar S; Mansur AT; Göktay F; Aydingöz IE
    Eur J Dermatol; 2007; 17(2):153-6. PubMed ID: 17337401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Generalized scleroderma and angioaccesses for hemodialysis].
    Martínez R; Pardo MP; Grau L; Modol J; Soler J
    Angiologia; 1989; 41(3):109-11. PubMed ID: 2751148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.